Vitalhub Corp. (TSE:VHI – Free Report) – Equities research analysts at Cormark lowered their FY2025 earnings estimates for Vitalhub in a report released on Monday, May 12th. Cormark analyst G. Fairweather now expects that the company will post earnings per share of $0.16 for the year, down from their previous estimate of $0.23. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Cormark also issued estimates for Vitalhub’s FY2026 earnings at $0.29 EPS.
Other analysts have also issued research reports about the stock. TD Securities lifted their price objective on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a “buy” rating in a research note on Monday, March 31st. Raymond James set a C$13.50 price objective on shares of Vitalhub and gave the stock an “outperform” rating in a report on Thursday, March 27th. Canaccord Genuity Group boosted their price target on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a report on Thursday, January 16th. Finally, Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the company an “outperform” rating in a report on Thursday, January 30th. Four research analysts have rated the stock with a buy rating, According to MarketBeat, Vitalhub presently has an average rating of “Buy” and an average price target of C$12.90.
Vitalhub Stock Performance
TSE VHI opened at C$10.21 on Thursday. The firm has a market capitalization of C$552.28 million, a price-to-earnings ratio of 166.06, a PEG ratio of 1.18 and a beta of 1.26. The company’s 50 day moving average price is C$10.01 and its 200 day moving average price is C$10.65. Vitalhub has a one year low of C$6.68 and a one year high of C$12.34.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Recommended Stories
- Five stocks we like better than Vitalhub
- Stock Market Upgrades: What Are They?
- Walmart Stock Alert: Big Price Move Expected Soon
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Top Biotech Stocks: Exploring Innovation Opportunities
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.